Literature DB >> 17333217

Lack of association of the 3'-UTR polymorphism in the NFKBIA gene with Crohn's disease in an Israeli cohort.

E Leshinsky-Silver1, A Karban, S Cohen, M Fridlander, O Davidowich, G Kimmel, R Shamir, A Levine.   

Abstract

BACKGROUND: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract associated with dysregulation of the immune response. It is caused by a combination of environmental and genetic factors. Patients with CD have a TH1-type inflammatory response characterized by nuclear factor kappa B (NFkappaB) activation. Mutations in the bacterial pattern recognition receptors NOD2/CARD15 and Toll-like receptor 4 (TLR4) genes, which lead to activation of NFkappaB under normal circumstances, have been associated with increased susceptibility for CD. NFkappaB plays a critical role in the immune response and is down-regulated by NFkappaB inhibitor alpha (NFKBIA). NFKBIA was found to be a susceptibility gene for German CD patients lacking NOD2/CARD15 mutations.
MATERIALS AND METHODS: A cohort of 231 Israeli CD patients previously genotyped for the single nucleotide polymorphisms (SNPs) in the CARD15, TLR4 susceptibility genes for CD, was analyzed for the 3'-untranslated region (UTR) SNP of the NFKBIA gene in comparison to 100 healthy ethnically matched controls. We evaluated the contribution of the 3'-UTR SNP in NFKBIA in patients with or without other SNPs in CARD15 to age of onset, disease location, and disease behavior (Vienna classification).
RESULTS: We did not identify a significant difference in allele and genotype frequencies between either groups or an effect on phenotype. No interactions were found between NFKBIA and any NOD2.
CONCLUSIONS: The contribution of population diversity to susceptibility genes for CD plays an important role in disease-associated variants and is important for better understanding of the pathologic mechanisms of the polymorphism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333217     DOI: 10.1007/s00384-007-0287-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  30 in total

1.  A dynamic programming algorithm for haplotype block partitioning.

Authors:  Kui Zhang; Minghua Deng; Ting Chen; Michael S Waterman; Fengzhu Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  GERBIL: Genotype resolution and block identification using likelihood.

Authors:  Gad Kimmel; Ron Shamir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

4.  Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort.

Authors:  Esther Leshinsky-Silver; Amir Karban; Erena Buzhakor; Marcelo Fridlander; Benjamin Yakir; Rami Eliakim; Shimon Reif; Roni Shaul; Mona Boaz; Dorit Lev; Arie Levine
Journal:  Pediatr Res       Date:  2005-09       Impact factor: 3.756

5.  Polymorphisms in the 3' untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14.

Authors:  D Glavac; M Ravnik-Glavac; S J O'Brien; M Dean
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

6.  Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity.

Authors:  Eytan Wine; Shimon S Reif; Esther Leshinsky-Silver; Batya Weiss; Ron R Shaoul; Raanan Shamir; Dror Wasserman; Aaron Lerner; Mona Boaz; Arie Levine
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

7.  TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease.

Authors:  Arie Levine; Raanan Shamir; Eytan Wine; Batya Weiss; Amir Karban; Ron R Shaoul; Shimon S Reif; Benjamin Yakir; Marcello Friedlander; Yael Kaniel; Esther Leshinsky-Silver
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

8.  Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.

Authors:  B Miterski; S Böhringer; W Klein; E Sindern; M Haupts; S Schimrigk; J T Epplen
Journal:  Genes Immun       Date:  2002-06       Impact factor: 2.676

9.  Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.

Authors:  M F Neurath; I Fuss; G Schürmann; S Pettersson; K Arnold; H Müller-Lobeck; W Strober; C Herfarth; K H Büschenfelde
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

Review 10.  Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.

Authors:  Bill Newman; Katherine Siminovitch
Journal:  Clin Invest Med       Date:  2003-12       Impact factor: 0.825

View more
  1 in total

1.  Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Authors:  Guo-Long Zhang; Yan-Feng Zou; Xiao-Liang Feng; He-Jian Shi; Xu-Feng Du; Min-Hua Shao; Yong Gu; Qing Zhou
Journal:  Inflamm Res       Date:  2010-05-21       Impact factor: 4.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.